Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 276

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 19
Chunk 276
---
482)  
  Transfer to Cash-Settled LTIP                                               ( 85,930)                         ( 209,715)                                     
  Transfer to Cash-Settled RSU                                                                                                                                 
  At end of the year                     1,311,989           773,844         59,752,598         746,762         65,410,484         665,377         70,266,342  

The balance as of March 31, 2023, 2024 and 2025, each represents unvested awards. The weighted average remaining contractual life of the outstanding award points/units was one year one year one year

Cash-Settled Awards

Takeda previously provided a phantom stock appreciation rights (“ PSARs”) plan through the year ended March 31, 2014, and a restricted stock units (“ RSUs”) plan through the year ended March 31, 2021 for certain employees of subsidiaries of the Company. The value of these awards is linked to share price of the Company and are settled in cash. Moreover, where settlement of awards granted under the LTIP described under “ - Equity Settled Plans” above in ADSs or shares of common stock is not permissible due to legal, regulatory and/or administrative reasons, such awards are settled in cash. The total compensation expense recorded in association with these plans was JPY 352 639 717 1,026 1,018 642

Phantom stock appreciation rights (“ PSARs”)

The PSARs vest one third each year over a three-year ten years

The following table summarizes the award activity related to the PSARs (the number of awards) (1 award represents 1 share of the Company's common stock) :

                                       For the Year Ended March 31                                                                                                    
                                       2023                                                          2024                                            2025             
                                       Number of PSARs                                               Number of PSARs                                 Number of PSARs  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  As of beginning of the year                                              1,471,095      5,481                              217,530      5,956      —                
  Forfeited/expired after vesting                                       ( 1,253,565)      6,054                           ( 217,530)      6,428      —                
  As of end of the year                                                      217,